Henry Schein (NASDAQ:HSIC) Issues FY 2024 Earnings Guidance

Henry Schein (NASDAQ:HSIC) updated its FY 2024 earnings guidance on Tuesday. The company provided EPS guidance of 4.740-4.820 for the period, compared to the consensus EPS estimate of 4.750. The company issued revenue guidance of $12.8 billion-$13.0 billion, compared to the consensus revenue estimate of $12.9 billion.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several recent research reports. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Robert W. Baird reduced their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Friday, September 20th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein has an average rating of “Hold” and an average target price of $77.50.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $72.33 on Tuesday. Henry Schein has a 1-year low of $62.05 and a 1-year high of $82.63. The firm has a market capitalization of $9.16 billion, a price-to-earnings ratio of 26.79, a PEG ratio of 2.02 and a beta of 0.87. The company’s 50-day moving average is $70.66 and its two-hundred day moving average is $69.79. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same period in the prior year, the business posted $1.31 EPS. The business’s revenue for the quarter was up .0% compared to the same quarter last year. Analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.